Search

Author/Creator Subramanian, Ramkumar

2. 0139 SUVN-G3031, A Potent and Selective Histamine H3 Receptor Inverse Agonist - Phase-2 Investigational New Drug for the Treatment of Narcolepsy - Differentiating Factors with Competitor Clinical Candidates. (12th April 2019)

Authors:
Nirogi, Ramakrishna; Bhyrapuneni, Gopinadh; Abraham, Renny; Subramanian, Ramkumar; Goyal, Vinod Kumar; Pandey, Santosh Kumar; Badange, Rajesh; Shinde, Anil
Journal:
Sleep
Issue:
Volume 42(2019)Supplement 1
Page Start:
A57
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 1‐[2‐(1‐Cyclobutylpiperidin‐4‐yloxy)‐6, 7‐dihydro‐4H‐thiazolo[5, 4‐c]pyridin‐5‐yl]propan‐1‐one: a Histamine H3 Receptor Inverse Agonist with Efficacy in Animal Models of Cognition. (18th November 2021)

Authors:
Shinde, Anil Karbhari; Badange, Rajesh Kumar; Reballi, Veena; Achanta, Pramod Kumar; Bojja, Kumar; Manchineella, Sravanthi; Rao Muddana, Nageswara; Subramanian, Ramkumar; Choudary Palacharla, Raghava; Benade, Vijay; Jayarajan, Pradeep; Thentu, Jagadeesh Babu; Lingavarapu, Bujji Babu; Yarra, Sivas...
Journal:
ChemMedChem
Issue:
Volume 17:Number 3(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. [P1–063]: SUVN‐G3031, A SELECTIVE H3 RECEPTOR INVERSE AGONIST: ASSESSMENT OF SAFETY, TOLERABILITY AND PHARMACOKINETICS IN HEALTHY HUMAN VOLUNTEERS. (1st July 2017)

Authors:
Muddana, NageswaraRao; Bhyrapuneni, Gopinadh; Mudigonda, Koteshwara; Jayarajan, Pradeep; Abraham, Renny; Subramanian, Ramkumar; Goyal, Vinod Kumar; Pandey, Santosh Kumar; Boggavarapu, Rajesh Kumar; Ajjala, Devender Reddy; Shinde, Anil K.; Nirogi, Ramakrishna
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 5
Page Start:
P261
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. [P1–460]: SUVN‐D4010: A POTENT AND SELECTIVE 5‐HT4 RECEPTOR PARTIAL AGONIST— ASSESSMENT OF SAFETY, TOLERABILITY AND PHARMACOKINETICS IN HEALTHY HUMAN VOLUNTEERS. (1st July 2017)

Authors:
Bhyrapuneni, Gopinadh; Mudigonda, Koteshwara; Chowdary Palacharla, Veera Raghava; Jayarajan, Pradeep; Abraham, Renny; Subramanian, Ramkumar; Goyal, Vinod Kumar; Pandey, Santosh Kumar; Boggavarapu, Rajesh Kumar; Ajjala, Devender Reddy; Rasheed, Mohammed Abdul; Nirogi, Ramakrishna
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 9
Page Start:
P463
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Effect of Concurrent Use of Memantine on The Efficacy of Masupirdine (SUVN‐502): A Post‐hoc Analysis of a Phase‐2 Randomized Placebo‐Controlled Study. (20th December 2022)

Authors:
Goyal, Vinod Kumar; Pandey, Santosh Kumar; Benade, Vijay; Shinde, Anil K; Rasheed, Mohammed Abdul; Badange, Rajesh Kumar; Palacharla, Veera Raghava Chowdary; Ravulu, Jyothsna; Jetta, Satish; Subramanian, Ramkumar; Nirogi, Ramakrishna
Journal:
Alzheimer's & dementia
Issue:
Volume 18(2022)Supplement 10
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Effects of Masupirdine (SUVN‐502) on Agitation/Aggression and Psychosis in Patients with Probable Alzheimer's Disease: A Post Hoc Analysis. (20th December 2022)

Authors:
Nirogi, Ramakrishna; Jayarajan, Pradeep; Abraham, Renny; Tadiparthi, Jayaprakash; Benade, Vijay; Shinde, Anil K; Rasheed, Mohammed Abdul; Badange, Rajesh Kumar; Goyal, Vinod Kumar; Palacharla, Veera Raghava Chowdary; Ravulu, Jyothsna; Jetta, Satish; Subramanian, Ramkumar
Journal:
Alzheimer's & dementia
Issue:
Volume 18(2022)Supplement 10
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Histamine 3 receptor inverse agonist Samelisant (SUVN-G3031): Pharmacological characterization of an investigational agent for the treatment of cognitive disorders. (June 2021)

Authors:
Nirogi, Ramakrishna; Grandhi, Venkata R; Medapati, Rajesh B; Ganuga, Narender; Benade, Vijay; Gandipudi, Sudhakar; Manoharan, Arunkumar; Abraham, Renny; Jayarajan, Pradeep; Bhyrapuneni, Gopinadh; Shinde, Anil; Badange, Rajesh K; Subramanian, Ramkumar; Petlu, Surendra; Jasti, Venkat
Journal:
Journal of psychopharmacology
Issue:
Volume 35:Number 6(2021)
Page Start:
713
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Masupirdine (SUVN‐502) in combination with donepezil and memantine in moderate Alzheimer's disease: Effect of AD duration since diagnosis and patient's age on efficacy endpoints: Human/Human trials: Cognitive enhancement. (7th December 2020)

Authors:
Nirogi, Ramakrishna; Shinde, Anil K; Benade, Vijay; Subramanian, Ramkumar; Bhyrapuneni, Gopinadh; Ravulu, Jyothsna; Jetta, Satish; Rasheed, Mohammed Abdul; Badange, Rajesh Kumar; Jasti, Venkat
Journal:
Alzheimer's & dementia
Issue:
Volume 16(2020)Supplement 9
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. P1‐077: IN‐VITRO CHARACTERIZATION OF SUVN‐I2004: A NOVEL MUSCARINIC M1 POSITIVE ALLOSTERIC MODULATOR. (1st July 2006)

Authors:
Subramanian, Ramkumar; Mekala, Venkat Reddy; Srirangavaram, Maheswari; Mary, Praveena Nissankararao; Edula, Surekha; Petlu, Surendra; Irappanavar, Shantaveer M.; Rasheed, Mohammed Abdul; Nirogi, Ramakrishna
Journal:
Alzheimer's & dementia
Issue:
Volume 14:Supplement 7S(2018)Part 5
Page Start:
P300
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗